
|Slideshows|May 23, 2018
Antibody Testing in Patients With Neurological and Psychiatric Symptoms
Author(s)Veronica Hackethal, MD
New research may help doctors determine when (and when not) to test for antiglutamate decarboxylase antibodies in patients with neurological disorders and psychiatric symptoms.
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
A Step Forward in Multiple System Atrophy: Phase 2 Findings Reinforce ATH434’s Disease-Modifying Potential
2
NeuroVoices: Gerald Maguire, MD, on Raising Awareness of the Neurobiology of Stuttering
3
Incorporating AI Into Stroke Triage
4
Earlier Initiation of Pimavanserin Leads to Better Improvement of Parkinson Disease Psychosis Symptoms
5